Related Experiment Video
Updated: May 29, 2025

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
Brief, Low-impact, High-intensity Osteogenic Loading in Postmenopausal Osteoporosis: A Quasi-experimental Case-series
Nektaria Papadopoulou-Marketou1,2, Anna Papageorgiou2, Nikolaos Marketos3
1Neuroendocrine Tumor Unit, ENETS Centre of Excellence, 1st Department of Propaedeutic and Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Osteostrong® exercises improved bone mineral density (BMD) and trabecular bone score (TBS) in postmenopausal women with osteoporosis. The intervention enhanced the effects of antiresorptive therapy, showing significant gains in spinal and hip BMD.
Area of Science:
- Orthopedics and Sports Medicine
- Gerontology
- Bone Health Research
Background:
- Osteoporosis is a condition characterized by low bone mineral density (BMD) and compromised bone microarchitecture, leading to increased fracture risk.
- The trabecular bone score (TBS) is a key metric for assessing bone microarchitecture.
- Osteostrong® is a novel system utilizing osteogenic loading exercises designed to strengthen bone.
Purpose of the Study:
- To evaluate the efficacy of the Osteostrong® intervention in improving bone health markers in postmenopausal women diagnosed with osteoporosis.
- To assess whether Osteostrong® can enhance the benefits of existing antiresorptive therapies.
Main Methods:
- A study involving 147 postmenopausal osteoporotic women was conducted.
- Participants were divided into intervention (Osteostrong®) and control groups, with subgroups receiving or not receiving antiresorptive medication.
- Dual-energy X-ray absorptiometry (DXA) and trabecular bone score (TBS) assessments were performed at baseline and after 12 months.
Main Results:
- Significant increases in lumbar spine BMD were observed in both Osteostrong® intervention and control groups, with notable improvements in those on antiresorptive therapy.
- The Osteostrong® group showed significant improvements in TBS and BMD of the femoral neck and total femur.
- Osteostrong® intervention led to statistically significant increases in BMD across multiple skeletal sites.
Conclusions:
- The Osteostrong® intervention effectively improved lumbar spine BMD in postmenopausal women with osteoporosis, irrespective of antiresorptive medication use.
- Osteostrong® demonstrated an additive benefit when combined with antiresorptive therapy, enhancing BMD and TBS at the spine and hip.
- These findings suggest Osteostrong® is a promising non-pharmacological approach to manage osteoporosis and improve bone health markers.
More Related Videos
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...